ProQR Therapeutics (PRQR) Non-cash Items (2017 - 2024)

ProQR Therapeutics (PRQR) posted quarterly Non-cash Items of -$6.4 million for Q3 2024, up 24.65% year-on-year from -$5.2 million in Q4 2023, and up 17.72% on a QoQ basis from -$7.8 million in Q2 2024.

ProQR Therapeutics (PRQR) Non-cash Items (2017 - 2024) Analysis & Trends

ProQR Therapeutics (PRQR) has reported Non-cash Items for 7 consecutive years, with -$6.4 million the latest figure, recorded in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 ProQR Therapeutics 219.53 Mn 175.72 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 -6.44 Mn
Sep 30, 2024 -6.44 Mn
Jun 30, 2024 -7.82 Mn
Jun 30, 2024 -7.82 Mn
Mar 31, 2024 -17.22 Mn
Mar 31, 2024 -17.22 Mn
Sep 30, 2023 -8.54 Mn
Sep 30, 2023 -8.54 Mn
Jun 30, 2023 -12.55 Mn
Jun 30, 2023 -12.55 Mn
Mar 31, 2023 50.90 Mn
Mar 31, 2023 50.90 Mn
Sep 30, 2022 -16.24 Mn
Sep 30, 2022 -16.24 Mn
Jun 30, 2022 -21.90 Mn
Jun 30, 2022 -21.90 Mn
Mar 31, 2020 -17.11 Mn
Mar 31, 2020 -17.11 Mn
Sep 30, 2019 -10.07 Mn
Sep 30, 2019 -10.07 Mn